or
forgot password

Development of Positive Psychotherapy for Smoking Cessation


Phase 2
18 Years
N/A
Open (Enrolling)
Both
Smoking

Thank you

Trial Information

Development of Positive Psychotherapy for Smoking Cessation


Inclusion Criteria:



- smoke at least 5 cigarettes per day for longer than one year with no other ongoing
tobacco product use

- willing to use the transdermal nicotine patch

- report at least a 5 on a 0 to 10 scale rating the importance of quitting smoking.

Exclusion Criteria:

- are currently experiencing psychotic symptoms, affective disorder (major depression,
dysthymia, or mania) or substance use disorder (other than nicotine dependence)

- taking prescribed psychotropic medication or receiving other forms of psychotherapy

- concomitantly using other pharmacotherapies for smoking cessation

- have any contraindications for use of the transdermal nicotine patch.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

7-day point prevalence smoking abstinence

Outcome Description:

Biochemically verified abstinence from smoking over the past 7 days

Outcome Time Frame:

8 weeks

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

NCI-156241-1

NCT ID:

NCT01451814

Start Date:

October 2011

Completion Date:

December 2013

Related Keywords:

  • Smoking
  • smoking cessation
  • Smoking

Name

Location

Center for Alcohol and Addiction Studies, Brown University Providence, Rhode Island  02912